Eight years after the pandemic influenza outbreak, a lawsuit alleging that GlaxoSmithKline's
Pandemrix vaccine caused narcolepsy has unearthed internal reports suggesting problems
with the vaccine's safety. Peter Doshi asks what this means for the future of transparency
during public health emergencies